首页> 外文期刊>The Journal of Antibiotics: An International Journal >Discovery and antibacterial activity of glabramycin A-C from Neosartorya glabra by an antisense strategy.
【24h】

Discovery and antibacterial activity of glabramycin A-C from Neosartorya glabra by an antisense strategy.

机译:通过反义策略从NeoSartorya Glabra发现和抗菌活性A-C.

获取原文
获取原文并翻译 | 示例
           

摘要

Treatment of drug-resistant bacteria is a significant unmet medical need. This challenge can be met only by the discovery and development of new antibiotics. Antisense technology is one of the newest discovery tools that provides enhanced sensitivity for detection of antibacterials, and has led to the discovery of a number of interesting new antibacterial natural products. Continued utilization of this technology led to the discovery of three new bicyclic lactones, glabramycins A-C, from a Neosartorya glabra strain. Glabramycin C showed strong antibiotic activity against Streptococcus pneumoniae (MIC 2 microg ml(-1)) and modest antibiotic activity against Staphylococcus aureus (MIC 16 microg ml(-1)). The isolation, structure, relative configuration and antibacterial activity, and plausible biogenesis of these compounds have been discussed.
机译:耐药细菌的治疗是一个显着的未满足的医疗需求。 这种挑战只能通过新抗生素的发现和开发来满足。 反义技术是最新的发现工具之一,可提供增强的检测抗菌性敏感性,并导致了许多有趣的新抗菌天然产物的发现。 继续利用这项技术导致了三种新的双环内酯,从NeoSartorya Glabra菌株发现了三种新的双环内酯。 Glabramycin C对肺炎链球菌(MIC 2 microgl Ml(-1))和对葡萄球菌的适度抗生素活性显示出强烈的抗生素活性(MIC 16 microg ml(-1))。 已经讨论了这些化合物的分离,结构,相对构型和抗菌活性,以及这些化合物的合理生物发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号